Prognostic role of BRAF mutation in malignant cutaneous melanoma.

被引：1
|
作者：
Sehdev, Amikar
Hayden, Ross
Kuhar, Mathew Joseph
Cheng, Liang
Warren, Simon John
Mark, Lawrence Aaron
Wooden, William Arthur
Schwartzentruber, Douglas Jay
Logan, Theodore F.
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Regenstrief Inst Hlth Care, Indianapolis, IN USA
[3] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[4] Indiana Univ Hosp, 550 N Univ Blvd, Indianapolis, IN 46202 USA
[5] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21599
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21599
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cutaneous malignant melanoma. The role of PET-CT
    Antonio Serna-Macias, Jose
    Sanchez-Casas, Nicolas R.
    Emilio Morato-Lopez, Alberto
    Natalia Reyes-Garcia, Monica
    Manuel Isusi-Alcazar, Juan
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (02): : 104 - 112
  • [2] BRAF mutation as a pejorative marker in metastatic melanoma.
    Brissy, Sophie
    Gaudy-Marqueste, Caroline
    Mallet, Stephanie
    Monestier, Sandrine
    Hesse, Sylvie
    Koeppel, Marie-Christine
    Rojat-Habib, Marie-Christine
    Nanni, Isabelle
    Loundou, Anderson
    Ouafik, L'houcine
    Bonnet, Nathalie
    Richard, Marie-Aleth
    Grob, Jean Jacques
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma
    Scatolini, M.
    Patel, A.
    Grosso, E.
    Mello-Grand, M.
    Ostano, P.
    Coppo, R.
    Vitiello, M.
    Venesio, T.
    Zaccagna, A.
    Pisacane, A.
    Sarotto, I
    Taverna, D.
    Poliseno, L.
    Bergamaschi, D.
    Chiorino, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : 117 - 128
  • [4] Surgical management of cutaneous malignant melanoma.: Review
    Lavie, A.
    Desouches, C.
    Casanova, D.
    Bardot, J.
    Grob, J. -J.
    Legre, R.
    Magalon, G.
    [J]. ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE, 2007, 52 (01): : 1 - 13
  • [5] Cytomorphometry as a prognostic factor for uveal and cutaneous melanoma.
    Lavinsky, F
    Pereira, F
    Correia, CP
    Carey, W
    Burnier, MN
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S381 - S381
  • [6] Malignant melanoma The role of BRAF inhibition in malignant melanoma
    Zaremba, A.
    Zimmer, L.
    Griewank, K. G.
    Ugurel, S.
    Roesch, A.
    Schadendorf, D.
    Livingstone, E.
    [J]. ONKOLOGE, 2020, 26 (08): : 713 - 720
  • [7] Oncogenic BRAF mutation in cutaneous melanoma in Argentina
    Boggio, G.
    Falco, A.
    Maur Perotti, J.
    Videla, V.
    Garcia Rivello, H.
    Gutierrez, M.
    Nunez, M.
    Chacon, M.
    Pallotta, M. G.
    Romero, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S871 - S871
  • [8] BRAF mutation and FISH in the prognosis of cutaneous melanoma
    Nardone, B.
    Barahmani, N.
    Pouryazdanparast, P.
    Martini, M.
    Rademaker, A.
    West, D. P.
    Gerami, P.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S130 - S130
  • [9] Impact of BRAF mutation in patients with brain metastasis from melanoma.
    Venur, Vyshak Alva
    Kotecha, Rupesh
    Chen, Zhijian
    Chao, Samuel T.
    Elson, Paul
    Suh, John H.
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients
    Tas, Faruk
    Erturk, Kayhan
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (02)
12345